The present disclosure provides compounds and pharmaceutically acceptable salts that are tyrosine kinase inhibitors, in particular BLK, BMX, EGFR, HER2, HER4, ITK, JAK3, TEC, BTK, and TXK and are therefore useful for the treatment of diseases treatable by inhibition of tyrosine kinases such as cancer and inflammatory diseases such as arthritis, and the like. Also provided are pharmaceutical compositions containing such compounds and pharmaceutically acceptable salts and processes for preparing such compounds and pharmaceutically acceptable salts.
本公开提供的化合物及其药物可接受的盐是
酪氨酸激酶
抑制剂,特别是BLK、B
MX、
EGFR、
HER2、
HER4、ITK、JAK3、
TEC、
BTK和TXK,因此可用于治疗通过抑制
酪氨酸激酶治疗的疾病,如癌症和炎症性疾病,如关节炎等。还提供了含有这些化合物和药物可接受的盐的制药组合物以及制备这些化合物和药物可接受的盐的过程。